LUCD insider trading

NasdaqCM Healthcare

Lucid Diagnostics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
61
Last 90 days
11
Buys / sells
13% / 20%
Market cap
$191.40M

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Company website: www.luciddx.com

LUCD insider activity at a glance

FilingIQ has scored 61 insider transactions for LUCD since Oct 18, 2021. The most recent filing in our index is dated Feb 20, 2026.

Across the full history, 8 open-market purchases and 12 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LUCD insider trades is 47.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for LUCD?
FilingIQ tracks 61 Form 4 insider transactions for LUCD (Lucid Diagnostics Inc.), covering filings from Oct 18, 2021 onwards. 11 of those were filed in the last 90 days.
Are LUCD insiders net buyers or net sellers?
Across the full Form 4 history for LUCD, 8 transactions (13%) were open-market purchases and 12 (20%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LUCD insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is LUCD in?
Lucid Diagnostics Inc. (LUCD) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $191.40M.

Methodology & sources

Every LUCD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.